Factors affecting the nuclear localization of β-catenin in normal and malignant tissue

Journal of Cellular Biochemistry

Volumn 115, Issue 8, 2014, Pages 1351-1361

  Morgan, Rhys G ^a   Ridsdale, Jenna ^b   Tonks, Alex ^b   Darley, Richard L ^b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

cancer; leukemia; nuclear translocation localization; Wnt; catenin

Indexed keywords

BETA CATENIN; CHAPERONE; NUCLEAR PROTEIN; T CELL FACTOR PROTEIN;

ACTIVE TRANSPORT; ARTICLE; CANCER CELL; CANCER TISSUE; CELL DIFFERENTIATION; CELL NUCLEUS MEMBRANE; CYTOSOL; HUMAN; HUMAN CELL; MEMBRANE COMPONENT; NUCLEAR IMPORT; NUCLEAR PORE; NUCLEAR PORE COMPLEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; TRANSCRIPTION INITIATION; WNT SIGNALING PATHWAY; BIOSYNTHESIS; CELL NUCLEUS; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; NEOPLASM; PATHOLOGY; SIGNAL TRANSDUCTION;

BETA CATENIN; CELL NUCLEUS; HUMANS; NEOPLASMS; SIGNAL TRANSDUCTION; TCF TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; WNT SIGNALING PATHWAY;

EID: 84902436559     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24803     Document Type: Article

References (93)

1. Aberle H, Bauer A, Stappert J, Kispert A, Kemler R,. 1997. Beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J 16: 3797-3804.
2. Abraham SC, Nobukawa B, Giardiello FM, Hamilton SR, Wu TT,. 2001. Sporadic fundic gland polyps: Common gastric polyps arising through activating mutations in the beta-catenin gene. Am J Pathol 158: 1005-1010.
3. Anderson CB, Neufeld KL, White RL,. 2002. Subcellular distribution of Wnt pathway proteins in normal and neoplastic colon. Proc Natl Acad Sci U S A 99: 8683-8688.
4. Anna CH, Sills RC, Foley JF, Stockton PS, Ton TV, Devereux TR,. 2000. Beta-catenin mutations and protein accumulation in all hepatoblastomas examined from B6C3F1 mice treated with anthraquinone or oxazepam. Cancer Res 60: 2864-2868.
5. Baldus SE, Monig SP, Huxel S, Landsberg S, Hanisch FG, Engelmann K, Schneider PM, Thiele J, Holscher AH, Dienes HP,. 2004. MUC1 and nuclear beta-catenin are coexpressed at the invasion front of colorectal carcinomas and are both correlated with tumor prognosis. Clin Cancer Res 10: 2790-2796.
6. Behrens J, von Kries JP, Kuhl M, Bruhn L, Wedlich D, Grosschedl R, Birchmeier W,. 1996. Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382: 638-642.
7. Belenkaya TY, Han C, Standley HJ, Lin X, Houston DW, Heasman J, Lin X,. 2002. Pygopus encodes a nuclear protein essential for wingless/Wnt signaling. Development 129: 4089-4101.
8. Blaker H, Scholten M, Sutter C, Otto HF, Penzel R,. 2003. Somatic mutations in familial adenomatous polyps. Nuclear translocation of beta-catenin requires more than biallelic APC inactivation. Am J Clin Pathol 120: 418-423.
9. Brabletz T, Jung A, Hermann K, Gunther K, Hohenberger W, Kirchner T,. 1998. Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front. Pathol Res Pract 194: 701-704.
10. Brabletz T, Herrmann K, Jung A, Faller G, Kirchner T,. 2000. Expression of nuclear beta-catenin and c-myc is correlated with tumor size but not with proliferative activity of colorectal adenomas. Am J Pathol 156: 865-870.
11. Brabletz T, Jung A, Reu S, Porzner M, Hlubek F, Kunz-Schughart LA, Knuechel R, Kirchner T,. 2001. Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci U S A 98: 10356-10361.
12. Brembeck FH, Schwarz-Romond T, Bakkers J, Wilhelm S, Hammerschmidt M, Birchmeier W,. 2004. Essential role of BCL9-2 in the switch between beta-catenin's adhesive and transcriptional functions. Genes Dev 18: 2225-2230.
13. Cao Y, Liu R, Jiang X, Lu J, Jiang J, Zhang C, Li X, Ning G,. 2009. Nuclear-cytoplasmic shuttling of menin regulates nuclear translocation of {beta}-catenin. Mol Cell Biol 29: 5477-5487.
14. Chen J, Wu A, Sun H, Drakas R, Garofalo C, Cascio S, Surmacz E, Baserga R,. 2005. Functional significance of type 1 insulin-like growth factor-mediated nuclear translocation of the insulin receptor substrate-1 and beta-catenin. J Biol Chem 280: 29912-29920.
15. Clevers H, Nusse R,. 2012. Wnt/beta-catenin signaling and disease. Cell 149: 1192-1205.
16. Coluccia AM, Vacca A, Dunach M, Mologni L, Redaelli S, Bustos VH, Benati D, Pinna LA, Gambacorti-Passerini C,. 2007. Bcr-Abl stabilizes beta-catenin in chronic myeloid leukemia through its tyrosine phosphorylation. EMBO J 26: 1456-1466.
17. Cong F, Varmus H,. 2004. Nuclear-cytoplasmic shuttling of Axin regulates subcellular localization of beta-catenin. Proc Natl Acad Sci U S A 101: 2882-2887.
18. Eleftheriou A, Yoshida M, Henderson BR,. 2001. Nuclear export of human beta-catenin can occur independent of CRM1 and the adenomatous polyposis coli tumor suppressor. J Biol Chem 276: 25883-25888.
19. Fagotto F, Gluck U, Gumbiner BM,. 1998. Nuclear localization signal-independent and importin/karyopherin-independent nuclear import of beta-catenin. Curr Biol 8: 181-190.
20. Fu Y, Zhu H, Wu W, Xu J, Chen T, Xu B, Qian S, Li J, Liu P,. 2014. Clinical significance of lymphoid enhancer-binding factor 1 expression in acute myeloid leukemia. Leuk Lymphoma 55: 371-377.
21. Funayama N, Fagotto F, McCrea P, Gumbiner BM,. 1995. Embryonic axis induction by the armadillo repeat domain of beta-catenin: evidence for intracellular signaling. J Cell Biol 128: 959-968.
22. Gasiorowski JZ, Dean DA,. 2003. Mechanisms of nuclear transport and interventions. Adv Drug Deliv Rev 55: 703-716.
23. Gaspar C, Fodde R,. 2004. APC dosage effects in tumorigenesis and stem cell differentiation. Int J Dev Biol 48: 377-386.
24. Giannini A, Mazor M, Orme M, Vivanco M, Waxman J, Kypta R,. 2004. Nuclear export of alpha-catenin: Overlap between nuclear export signal sequences and the beta-catenin binding site. Exp Cell Res 295: 150-160.
25. Harris TJ, Peifer M,. 2005. Decisions, decisions: Beta-catenin chooses between adhesion and transcription. Trends Cell Biol 15: 234-237.
26. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW,. 1998. Identification of c-MYC as a target of the APC pathway. Science 281: 1509-1512.
27. Henderson BR,. 2000. Nuclear-cytoplasmic shuttling of APC regulates beta-catenin subcellular localization and turnover. Nat Cell Biol 2: 653-660.
28. Henderson BR, Galea M, Schuechner S, Leung L,. 2002. Lymphoid enhancer factor-1 blocks adenomatous polyposis coli-mediated nuclear export and degradation of beta-catenin. Regulation by histone deacetylase 1. J Biol Chem 277: 24258-24264.
29. Hendriksen J, Fagotto F, van der Velde H, van Shie M, Noordermeer J, Fornerod M,. 2005. RanBP3 enhances nuclear export of active (beta)-catenin independently of CRM1. J Cell Biol 171: 785-797.
30. Huang L, Ren J, Chen D, Li Y, Kharbanda S, Kufe D,. 2003. MUC1 cytoplasmic domain coactivates Wnt target gene transcription and confers transformation. Cancer Biol Ther 2: 702-706.
31. Huber O, Korn R, McLaughlin J, Ohsugi M, Herrmann BG, Kemler R,. 1996. Nuclear localization of beta-catenin by interaction with transcription factor LEF-1. Mech Dev 59: 3-10.
32. Hutten S, Kehlenbach RH,. 2007. CRM1-mediated nuclear export: to the pore and beyond. Trends Cell Biol 17: 193-201.
33. Inomata M, Ochiai A, Akimoto S, Kitano S, Hirohashi S,. 1996. Alteration of beta-catenin expression in colonic epithelial cells of familial adenomatous polyposis patients. Cancer Res 56: 2213-2217.
34. Jamieson C, Sharma M, Henderson BR,. 2011. Regulation of beta-catenin nuclear dynamics by GSK-3beta involves a LEF-1 positive feedback loop. Traffic 12: 983-999.
35. Jian H, Shen X, Liu I, Semenov M, He X, Wang XF,. 2006. Smad3-dependent nuclear translocation of beta-catenin is required for TGF-beta1-induced proliferation of bone marrow-derived adult human mesenchymal stem cells. Genes Dev 20: 666-674.
36. Kajiguchi T, Chung EJ, Lee S, Stine A, Kiyoi H, Naoe T, Levis MJ, Neckers L, Trepel JB,. 2007. FLT3 regulates beta-catenin tyrosine phosphorylation, nuclear localization, and transcriptional activity in acute myeloid leukemia cells. Leukemia 21: 2476-2484.
37. Kajiguchi T, Lee S, Lee MJ, Trepel JB, Neckers L,. 2008. KIT regulates tyrosine phosphorylation and nuclear localization of beta-catenin in mast cell leukemia. Leuk Res 32: 761-770.
38. Kau TR, Way JC, Silver PA,. 2004. Nuclear transport and cancer: From mechanism to intervention. Nat Rev Cancer 4: 106-117.
39. Kobayashi M, Honma T, Matsuda Y, Suzuki Y, Narisawa R, Ajioka Y, Asakura H,. 2000. Nuclear translocation of beta-catenin in colorectal cancer. Br J Cancer 82: 1689-1693.
40. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, Vogelstein B, Clevers H,. 1997. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 275: 1784-1787.
41. Kramps T, Peter O, Brunner E, Nellen D, Froesch B, Chatterjee S, Murone M, Zullig S, Basler K,. 2002. Wnt/wingless signaling requires BCL9/legless-mediated recruitment of pygopus to the nuclear beta-catenin-TCF complex. Cell 109: 47-60.
42. Krieghoff E, Behrens J, Mayr B,. 2006. Nucleo-cytoplasmic distribution of beta-catenin is regulated by retention. J Cell Sci 119: 1453-1463.
43. Kufe DW,. 2009. Mucins in cancer: Function, prognosis and therapy. Nat Rev Cancer 9: 874-885.
44. Li TF, Chen D, Wu Q, Chen M, Sheu TJ, Schwarz EM, Drissi H, Zuscik M, O'Keefe RJ,. 2006. Transforming growth factor-beta stimulates cyclin D1 expression through activation of beta-catenin signaling in chondrocytes. J Biol Chem 281: 21296-21304.
45. Li FQ, Mofunanya A, Harris K, Takemaru K,. 2008. Chibby cooperates with 14-3-3 to regulate beta-catenin subcellular distribution and signaling activity. J Cell Biol 181: 1141-1154.
46. Li FQ, Mofunanya A, Fischer V, Hall J, Takemaru K,. 2010. Nuclear-cytoplasmic shuttling of Chibby controls beta-catenin signaling. Mol Biol Cell 21: 311-322.
47. Li Y, Yi H, Yao Y, Liao X, Xie Y, Yang J, Yan Z, Wang L, Lu S, Kuang Y, Gu M, Fei J, Wang Z, Huang L,. 2011. The cytoplasmic domain of MUC1 induces hyperplasia in the mammary gland and correlates with nuclear accumulation of beta-catenin. PLoS ONE 6: e19102.
48. Li VS, Ng SS, Boersema PJ, Low TY, Karthaus WR, Gerlach JP, Mohammed S, Heck AJ, Maurice MM, Mahmoudi T, Clevers H,. 2012a. Wnt signaling through inhibition of beta-catenin degradation in an intact Axin1 complex. Cell 149: 1245-1256.
49. Li Y, Shao Y, Tong Y, Shen T, Zhang J, Li Y, Gu H, Li F,. 2012b. Nucleo-cytoplasmic shuttling of PAK4 modulates beta-catenin intracellular translocation and signaling. Biochim Biophys Acta 1823: 465-475.
50. Luis TC, Naber BA, Roozen PP, Brugman MH, de Haas EF, Ghazvini M, Fibbe WE, van Dongen JJ, Fodde R, Staal FJ,. 2011. Canonical wnt signaling regulates hematopoiesis in a dosage-dependent fashion. Cell Stem Cell 9: 345-356.
51. Ma RY, Tong TH, Cheung AM, Tsang AC, Leung WY, Yao KM,. 2005. Raf/MEK/MAPK signaling stimulates the nuclear translocation and transactivating activity of FOXM1c. J Cell Sci 118: 795-806.
52. Markiewicz E, Tilgner K, Barker N, van de Wetering M, Clevers H, Dorobek M, Hausmanowa-Petrusewicz I, Ramaekers FC, Broers JL, Blankesteijn WM, Salpingidou G, Wilson RG, Ellis JA, Hutchison CJ,. 2006. The inner nuclear membrane protein emerin regulates beta-catenin activity by restricting its accumulation in the nucleus. EMBO J 25: 3275-3285.
53. Mikesch JH, Steffen B, Berdel WE, Serve H, Muller-Tidow C,. 2007. The emerging role of Wnt signaling in the pathogenesis of acute myeloid leukemia. Leukemia 21: 1638-1647.
54. Molenaar M, van de Wetering M, Oosterwegel M, Peterson-Maduro J, Godsave S, Korinek V, Roose J, Destree O, Clevers H,. 1996. XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos. Cell 86: 391-399.
55. Morgan RG, Pearn L, Liddiard K, Pumford SL, Burnett AK, Tonks A, Darley RL,. 2012. Gamma-Catenin is overexpressed in acute myeloid leukemia and promotes the stabilization and nuclear localization of beta-catenin. Leukemia 27: 336-343.
56. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW,. 1997. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275: 1787-1790.
57. Mulholland DJ, Cheng H, Reid K, Rennie PS, Nelson CC,. 2002. The androgen receptor can promote beta-catenin nuclear translocation independently of adenomatous polyposis coli. J Biol Chem 277: 17933-17943.
58. Nelson WJ, Nusse R,. 2004. Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303: 1483-1487.
59. Neufeld KL, Nix DA, Bogerd H, Kang Y, Beckerle MC, Cullen BR, White RL,. 2000a. Adenomatous polyposis coli protein contains two nuclear export signals and shuttles between the nucleus and cytoplasm. Proc Natl Acad Sci U S A 97: 12085-12090.
60. Neufeld KL, Zhang F, Cullen BR, White RL,. 2000b. APC-mediated downregulation of beta-catenin activity involves nuclear sequestration and nuclear export. EMBO Rep 1: 519-523.
61. Nguyen KT, Holloway MP, Altura RA,. 2012. The CRM1 nuclear export protein in normal development and disease. Mol Int J Biochem Mol Biol 3: 137-151.
62. Orsulic S, Peifer M,. 1996. An in vivo structure-function study of armadillo, the beta-catenin homologue, reveals both separate and overlapping regions of the protein required for cell adhesion and for wingless signaling. J Cell Biol 134: 1283-1300.
63. Paraf F, Jothy S, Van Meir EG,. 1997. Brain tumor-polyposis syndrome: two genetic diseases?. J Clin Oncol 15: 2744-2758.
64. Pawlowski JE, Ertel JR, Allen MP, Xu M, Butler C, Wilson EM, Wierman ME,. 2002. Liganded androgen receptor interaction with beta-catenin: nuclear co-localization and modulation of transcriptional activity in neuronal cells. J Biol Chem 277: 20702-20710.
65. Petropoulos K, Arseni N, Schessl C, Stadler CR, Rawat VP, Deshpande AJ, Heilmeier B, Hiddemann W, Quintanilla-Martinez L, Bohlander SK, Feuring-Buske M, Buske C,. 2008. A novel role for Lef-1, a central transcription mediator of Wnt signaling, in leukemogenesis. J Exp Med 205: 515-522.
66. Phelps RA, Chidester S, Dehghanizadeh S, Phelps J, Sandoval IT, Rai K, Broadbent T, Sarkar S, Burt RW, Jones DA,. 2009. A two-step model for colon adenoma initiation and progression caused by APC loss. Cell 137: 623-634.
67. Pilarsky C, Wenzig M, Specht T, Saeger HD, Grutzmann R,. 2004. Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data. Neoplasia 6: 744-750.
68. Prieve MG, Waterman ML,. 1999. Nuclear localization and formation of beta-catenin-lymphoid enhancer factor 1 complexes are not sufficient for activation of gene expression. Mol Cell Biol 19: 4503-4515.
69. Ribbeck K, Gorlich D,. 2001. Kinetic analysis of translocation through nuclear pore complexes. EMBO J 20: 1320-1330.
70. Rosenbluh J, Nijhawan D, Cox AG, Li X, Neal JT, Schafer EJ, Zack TI, Wang X, Tsherniak A, Schinzel AC, Shao DD, Schumacher SE, Weir BA, Vazquez F, Cowley GS, Root DE, Mesirov JP, Beroukhim R, Kuo CJ, Goessling W, Hahn WC,. 2012. Beta-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis. Cell 151: 1457-1473.
71. Seo E, Jho EH,. 2007. Axin-independent phosphorylation of APC controls beta-catenin signaling via cytoplasmic retention of beta-catenin. Biochem Biophys Res Commun 357: 81-86.
72. Sharma M, Jamieson C, Johnson M, Molloy MP, Henderson BR,. 2012. Specific armadillo repeat sequences facilitate beta-catenin nuclear transport in live cells via direct binding to nucleoporins Nup62, Nup153, and RanBP2/Nup358. J Biol Chem 287: 819-831.
73. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R, Ben-Ze'ev A,. 1999. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci U S A 96: 5522-5527.
74. Silva-Vargas V, Lo CC, Giangreco A, Ofstad T, Prowse DM, Braun KM, Watt FM,. 2005. Beta-catenin and Hedgehog signal strength can specify number and location of hair follicles in adult epidermis without recruitment of bulge stem cells. Dev Cell 9: 121-131.
75. Simcha I, Shtutman M, Salomon D, Zhurinsky J, Sadot E, Geiger B, Ben-Ze'ev A,. 1998. Differential nuclear translocation and transactivation potential of beta-catenin and plakoglobin. J Cell Biol 141: 1433-1448.
76. Simon M, Grandage VL, Linch DC, Khwaja A,. 2005. Constitutive activation of the Wnt/beta-catenin signalling pathway in acute myeloid leukaemia. Oncogene 24: 2410-2420.
77. Stewart M,. 2007. Molecular mechanism of the nuclear protein import cycle. Nat Rev Mol Cell Biol 8: 195-208.
78. Suh EK, Gumbiner BM,. 2003. Translocation of beta-catenin into the nucleus independent of interactions with FG-rich nucleoporins. Exp Cell Res 290: 447-456.
79. Tandon B, Peterson L, Gao J, Nelson B, Ma S, Rosen S, Chen YH,. 2011. Nuclear overexpression of lymphoid-enhancer-binding factor 1 identifies chronic lymphocytic leukemia/small lymphocytic lymphoma in small B-cell lymphomas. Mod Pathol 24: 1433-1443.
80. Thompson BJ,. 2004. A complex of Armadillo, Legless, and Pygopus coactivates dTCF to activate wingless target genes. Curr Biol 14: 458-466.
81. Thyssen G, Li TH, Lehmann L, Zhuo M, Sharma M, Sun Z,. 2006. LZTS2 is a novel beta-catenin-interacting protein and regulates the nuclear export of beta-catenin. Mol Cell Biol 26: 8857-8867.
82. Tolwinski NS, Wieschaus E,. 2001. Armadillo nuclear import is regulated by cytoplasmic anchor Axin and nuclear anchor dTCF/Pan. Development 128: 2107-2117.
83. Townsley FM, Thompson B, Bienz M,. 2004. Pygopus residues required for its binding to Legless are critical for transcription and development. J Biol Chem 279: 5177-5183.
84. Udhayakumar G, Jayanthi V, Devaraj N, Devaraj H,. 2007. Interaction of MUC1 with beta-catenin modulates the Wnt target gene cyclinD1 in H. pylori-induced gastric cancer. Mol Carcinog 46: 807-817.
85. van de Wetering M, Sancho E, de Verweij CLW, Oving I, Hurlstone A, van der Horn K, Batlle E, Coudreuse D, Haramis AP, Tjon-Pon-Fong M, Moerer P, van den Born M, Soete G, Pals S, Eilers M, Medema R, Clevers H,. 2002. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111: 241-250.
86. Wang Y, Kakinuma N, Zhu Y, Kiyama R,. 2006. Nucleo-cytoplasmic shuttling of human Kank protein accompanies intracellular translocation of beta-catenin. J Cell Sci 119: 4002-4010.
87. Wen Y, Caffrey TC, Wheelock MJ, Johnson KR, Hollingsworth MA,. 2003. Nuclear association of the cytoplasmic tail of MUC1 and beta-catenin. J Biol Chem 278: 38029-38039.
88. Wiechens N, Fagotto F,. 2001. CRM1- and Ran-independent nuclear export of beta-catenin. Curr Biol 11: 18-27.
89. Wiechens N, Heinle K, Englmeier L, Schohl A, Fagotto F,. 2004. Nucleo-cytoplasmic shuttling of Axin, a negative regulator of the Wnt-beta-catenin Pathway. J Biol Chem 279: 5263-5267.
90. Ye H, Kelly TF, Samadani U, Lim L, Rubio S, Overdier DG, Roebuck KA, Costa RH,. 1997. Hepatocyte nuclear factor 3/fork head homolog 11 is expressed in proliferating epithelial and mesenchymal cells of embryonic and adult tissues. Mol Cell Biol 17: 1626-1641.
91. Yokoya F, Imamoto N, Tachibana T, Yoneda Y,. 1999. Beta-catenin can be transported into the nucleus in a Ran-unassisted manner. Mol Biol Cell 10: 1119-1131.
92. Zhang M, Wang M, Tang X, Li TF, Zhang Y, Chen D,. 2010. Smad3 prevents beta-catenin degradation and facilitates beta-catenin nuclear translocation in chondrocytes. J Biol Chem 285: 8703-8710.
93. Zhang N, Wei P, Gong A, Chiu WT, Lee HT, Colman H, Huang H, Xue J, Liu M, Wang Y, Sawaya R, Xie K, Yung WK, Medema RH, He X, Huang S,. 2011. FoxM1 promotes beta-catenin nuclear localization and controls Wnt target-gene expression and glioma tumorigenesis. Cancer Cell 20: 427-442.